Unknown

Dataset Information

0

How To Design a Successful p53-MDM2/X Interaction Inhibitor: A Thorough Overview Based on Crystal Structures.


ABSTRACT: A recent therapeutic strategy in oncology is based on blocking the protein-protein interaction between the murine double minute (MDM) homologues MDM2/X and the tumor-suppressor protein p53. Inhibiting the binding between wild-type (WT) p53 and its negative regulators MDM2 and/or MDMX has become an important target in oncology to restore the antitumor activity of p53, the so-called guardian of our genome. Interestingly, based on the multiple disclosed compound classes and structural analysis of small-molecule-MDM2 adducts, the p53-MDM2 complex is perhaps the best studied and most targeted protein-protein interaction. Several classes of small molecules have been identified as potent, selective, and efficient inhibitors of the p53-MDM2/X interaction, and many co-crystal structures with the protein are available. Herein we review the properties as well as preclinical and clinical studies of these small molecules and peptides, categorized by scaffold type. A particular emphasis is made on crystallographic structures and the observed binding modes of these compounds, including conserved water molecules present.

SUBMITTER: Estrada-Ortiz N 

PROVIDER: S-EPMC4838565 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

How To Design a Successful p53-MDM2/X Interaction Inhibitor: A Thorough Overview Based on Crystal Structures.

Estrada-Ortiz Natalia N   Neochoritis Constantinos G CG   Dömling Alexander A  

ChemMedChem 20151216 8


A recent therapeutic strategy in oncology is based on blocking the protein-protein interaction between the murine double minute (MDM) homologues MDM2/X and the tumor-suppressor protein p53. Inhibiting the binding between wild-type (WT) p53 and its negative regulators MDM2 and/or MDMX has become an important target in oncology to restore the antitumor activity of p53, the so-called guardian of our genome. Interestingly, based on the multiple disclosed compound classes and structural analysis of s  ...[more]

Similar Datasets

| S-EPMC3248991 | biostudies-literature
| S-EPMC4798270 | biostudies-literature
| S-EPMC4591261 | biostudies-literature
| S-EPMC9027661 | biostudies-literature
| S-EPMC4247201 | biostudies-literature
| S-EPMC2676446 | biostudies-literature
| S-EPMC2804373 | biostudies-literature
| S-EPMC3436289 | biostudies-literature
| S-EPMC3747081 | biostudies-literature
| S-EPMC3057987 | biostudies-literature